Astellas Pharma Inc. (ALPMY)
OTCMKTS · Delayed Price · Currency is USD
11.48
+0.18 (1.59%)
Sep 5, 2025, 3:58 PM EDT
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of $20.72 billion as of September 5, 2025. Its market cap has increased by 2.93% in one year.
Market Cap
20.72B
Enterprise Value
25.31B
Revenue
13.48B
Ranking
n/a
PE Ratio
36.65
Stock Price
$11.48
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 6.96B to 20.72B, an increase of 197.59%. That is a compound annual growth rate of 3.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 20.72B | 18.55% |
| Dec 30, 2024 | 17.48B | -18.50% |
| Dec 29, 2023 | 21.44B | -22.67% |
| Dec 30, 2022 | 27.73B | -7.87% |
| Dec 30, 2021 | 30.10B | 5.02% |
| Dec 30, 2020 | 28.66B | -10.92% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 891.61M |
| Elite Pharmaceuticals | 751.15M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 631.79M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 394.86M |
| American Oncology Network | 353.52M |